Sign Up to like & get
recommendations!
1
Published in 2017 at "Histopathology"
DOI: 10.1111/his.13254
Abstract: PD‐1/PD‐L1 checkpoint immunotherapy has been proposed recently as a promising treatment in relapsed/refractory disease, used eventually in combination with traditional chemotherapy in different cancer settings. To date, no data are available concerning PD‐L1 expression in…
read more here.
Keywords:
carcinoma pre;
invasive lesions;
vater carcinoma;
ampulla vater ... See more keywords